REGULATED PRESS RELEASE published on 09/23/2024 at 17:35, 1 year 9 months ago Disclosure of transactions in own shares on September 16 to September 20, 2024
REGULATED PRESS RELEASE published on 09/16/2024 at 17:35, 1 year 9 months ago Disclosure of transactions in own shares on September 9 to September 13, 2024
BRIEF published on 09/11/2024 at 08:05, 1 year 9 months ago EURAZEO and Kurma Partners Invest in PanTera's EUR 93 Million Financing for Actinium-225 Production EURAZEO Healthcare Innovation Kurma Partners PanTera Investment Actinium-225 Production
REGULATED PRESS RELEASE published on 09/11/2024 at 08:00, 1 year 9 months ago EURAZEO AND KURMA PARTNERS INVEST IN THE EUR 93 MILLION FINANCING OF PANTERA TO ESTABLISH COMMERCIAL-SCALE PRODUCTION OF ACTINIUM-225 Eurazeo and Kurma Partners invest EUR 93 million in PanTera for Actinium-225 production to fight cancer, aiming to provide large-scale quantities by 2028 and cover 100,000 patients per year by 2029 EURAZEO Cancer Treatment Actinium-225 Kurma Partners European Healthcare
BRIEF published on 09/10/2024 at 17:40, 1 year 9 months ago Disclosure of Shares and Voting Rights as of August 31, 2024 Voting Rights Capital Shares AMF Compliance
REGULATED PRESS RELEASE published on 09/10/2024 at 17:35, 1 year 9 months ago Disclosure of the number of shares and the total number of voting rights as of August 31, 2024 Disclosure of the total number of shares and voting rights by Eurazeo SE as of August 31, 2024, in compliance with relevant regulations Voting Rights Shares Disclosure Regulations Eurazeo SE
REGULATED PRESS RELEASE published on 09/09/2024 at 17:35, 1 year 9 months ago Disclosure of transactions in own shares on September 2 to September 6, 2024
BRIEF published on 09/05/2024 at 08:05, 1 year 9 months ago EURAZEO Becomes New Shareholder in Moria Alongside Naxicap Partners EURAZEO Investment Moria Naxicap Partners Ophthalmic Surgery
REGULATED PRESS RELEASE published on 09/05/2024 at 08:00, 1 year 9 months ago EURAZEO, NEW SHAREHOLDER IN MORIA ALONGSIDE ITS HISTORIC SPONSOR NAXICAP PARTNERS Eurazeo becomes a shareholder in Moria, a top ophthalmic surgery leader, alongside Naxicap Partners. Moria plans to expand its expertise globally and enhance innovation Innovation EURAZEO Moria Naxicap Partners Ophthalmic Surgery
REGULATED PRESS RELEASE published on 09/02/2024 at 17:35, 1 year 9 months ago Disclosure of transactions in own shares on August 26 to August 30, 2024
Published on 06/27/2026 at 16:50, 14 hours 29 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 5 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 7 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 8 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 8 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 7 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 7 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 7 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 7 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 7 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 07:00, 2 days ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 2 days 23 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.